PROCTER & GAMBLE HEALTH | BANDARAM PHARMA PACKTECH | PROCTER & GAMBLE HEALTH/ BANDARAM PHARMA PACKTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 40.9 | 84.5% | View Chart |
P/BV | x | 10.6 | 13.5 | 78.4% | View Chart |
Dividend Yield | % | 2.0 | 0.3 | 695.7% |
PROCTER & GAMBLE HEALTH BANDARAM PHARMA PACKTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
BANDARAM PHARMA PACKTECH Mar-23 |
PROCTER & GAMBLE HEALTH/ BANDARAM PHARMA PACKTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 73 | 7,355.2% | |
Low | Rs | 3,883 | 22 | 17,852.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 62.4 | 1,186.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0.9 | 16,073.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 2.8 | 5,521.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.10 | 95,000.0% | |
Avg Dividend yield | % | 2.1 | 0.2 | 972.7% | |
Book value per share (Unadj.) | Rs | 447.6 | 10.3 | 4,355.7% | |
Shares outstanding (eoy) | m | 16.60 | 3.00 | 553.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.8 | 823.2% | |
Avg P/E ratio | x | 33.5 | 55.2 | 60.6% | |
P/CF ratio (eoy) | x | 29.8 | 16.9 | 176.8% | |
Price / Book Value ratio | x | 10.3 | 4.6 | 224.2% | |
Dividend payout | % | 68.7 | 11.6 | 591.0% | |
Avg Mkt Cap | Rs m | 76,761 | 142 | 54,037.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 6 | 32,264.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 187 | 6,564.3% | |
Other income | Rs m | 184 | 2 | 9,678.9% | |
Total revenues | Rs m | 12,480 | 189 | 6,595.6% | |
Gross profit | Rs m | 3,247 | 12 | 28,159.6% | |
Depreciation | Rs m | 281 | 6 | 4,803.4% | |
Interest | Rs m | 8 | 4 | 178.2% | |
Profit before tax | Rs m | 3,142 | 3 | 96,380.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 1 | 124,602.9% | |
Profit after tax | Rs m | 2,295 | 3 | 88,941.9% | |
Gross profit margin | % | 26.4 | 6.2 | 429.1% | |
Effective tax rate | % | 27.0 | 20.9 | 129.3% | |
Net profit margin | % | 18.7 | 1.4 | 1,357.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 151 | 7,777.9% | |
Current liabilities | Rs m | 6,791 | 73 | 9,241.7% | |
Net working cap to sales | % | 40.0 | 41.2 | 97.2% | |
Current ratio | x | 1.7 | 2.0 | 84.2% | |
Inventory Days | Days | 263 | 1 | 20,747.0% | |
Debtors Days | Days | 343 | 1,290 | 26.6% | |
Net fixed assets | Rs m | 10,617 | 51 | 20,817.5% | |
Share capital | Rs m | 166 | 30 | 553.3% | |
"Free" reserves | Rs m | 7,265 | 1 | 875,241.0% | |
Net worth | Rs m | 7,431 | 31 | 24,101.5% | |
Long term debt | Rs m | 0 | 76 | 0.0% | |
Total assets | Rs m | 22,330 | 202 | 11,068.6% | |
Interest coverage | x | 409.1 | 1.8 | 23,312.7% | |
Debt to equity ratio | x | 0 | 2.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.9 | 59.3% | |
Return on assets | % | 10.3 | 3.4 | 301.5% | |
Return on equity | % | 30.9 | 8.4 | 369.6% | |
Return on capital | % | 42.4 | 7.1 | 600.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -11 | -21,474.1% | |
From Investments | Rs m | -215 | -53 | 405.4% | |
From Financial Activity | Rs m | -985 | 45 | -2,203.4% | |
Net Cashflow | Rs m | 1,160 | -19 | -6,002.6% |
Indian Promoters | % | 0.0 | 75.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 199,700.0% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 25.0 | 192.7% | |
Shareholders | 56,778 | 4,337 | 1,309.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | BANDARAM PHARMA PACKTECH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.00% | 0.45% |
1-Month | -1.15% | -15.73% | 2.55% |
1-Year | 0.73% | -54.82% | 56.14% |
3-Year CAGR | -8.76% | 14.87% | 15.22% |
5-Year CAGR | 4.97% | 15.82% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the BANDARAM PHARMA PACKTECH share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of BANDARAM PHARMA PACKTECH the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of BANDARAM PHARMA PACKTECH.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
BANDARAM PHARMA PACKTECH paid Rs 0.1, and its dividend payout ratio stood at 11.6%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of BANDARAM PHARMA PACKTECH.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.